影响共同决策参与的因素 稳定冠状动脉疾病患者:混合方法研究协议
Xiangxu Meng1, Chengang Hong1, Xingwei Zhang1
1School of Nursing, Hangzhou Normal University, Hangzhou 311121, China.
Healthcare (Basel, Switzerland)
|September 28, 2024
概括
本研究研究了中国稳定冠状动脉病患者在共享决策 (SDM) 中的参与,采用混合方法方法. 调查结果将为改善SDM和患者参与治疗选择的干预措施提供信息.
科学领域:
- 心脏病学 心脏病学
- 健康心理学 心理健康心理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 共享决策 (SDM) 在现代医疗保健中至关重要,取代了过时的父权主义模式.
- 在冠状动脉疾病 (CAD) 患者中,患者参与SDM的比例较低.
- 计划行为理论 (TPB) 为了解SDM的意图和行为提供了一个框架.
研究的目的:
- 调查中国稳定冠状动脉疾病 (SCAD) 患者中SDM参与的情况.
- 了解SCAD患者与SDM的经验.
- 在TPB的指导下,探索影响SCAD患者参与SDM的因素.
主要方法:
- 一个解释性的连续混合方法设计,结合了定量和定性阶段.
- 使用便利抽样进行定量横截面调查 (n ≥252).
- 定性半结构面试 (n = 10-20) 使用最大变异抽样.
主要成果:
- 该研究将使用描述性统计和假设测试,统计显著性设置为p < 0.05.
- 结果将将SDM参与状态的定量发现与患者体验和影响因素的定性见解相结合.
- 整合阶段将提供对SCAD患者SDM的全面理解.
结论:
- 混合方法和TPB框架将全面评估影响SCAD患者SDM参与的因素.
- 调查结果将为有针对性的干预和医疗保健提供者沟通策略提供信息,以加强SDM.
- 由于单个网站的招聘,通用性可能受到限制,需要谨慎的解释.
相关概念视频
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:26Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
01:30Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
01:23Assessment of the Cardiovascular System I: Subjective Data
282
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
01:26Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2